Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Sentinel and non-sentinel lymph node metastases in patients with microinvasive breast cancer: a nationwide study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk of breast cancer among women with benign ovarian tumors: a Danish nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

PURPOSE: To determine the incidence and risk factors of sentinel lymph node (SN) and non-SN metastases in patients with microinvasive breast cancer (MIBC, T1mic). This to identify MIBC patients in whom axillary staging can be safely omitted.

METHODS: The Danish Breast Cancer Group database was used to identify a total of 409 women with breast cancer ≤ 1 mm who underwent sentinel lymph node biopsy (SLNB) between 2002 and 2015. After validation, 233 patients were eligible for the analysis. The incidence rates of SN and non-SN metastases were determined. The associations between clinicopathological variables and a positive SN [pN1, pN1mi, or pN0(i+)] were analyzed using univariate and multivariate designs.

RESULTS: Of 233 patients with MIBC, only 9 (3.9%) had SN macrometastases. An additional 18 (7.7%) and 23 (9.9%) had SN micrometastases and isolated tumor cells (ITCs), respectively. Of patients with SN macrometastases, two (22.2%) had non-SN macrometastases. In the adjusted analysis, a positive SN was associated with younger age (P = 0.0001) and a positive human epidermal growth factor 2 receptor (HER2) status (P = 0.03).

CONCLUSIONS: The low incidence of SN macrometastases < 4% suggests omission of axillary staging in MIBC patients without staging at primary surgery, especially in older (≥ 50 years) HER2- patients. Still, the relatively high proportion of patients with non-SN macrometastases indicates that axillary treatment might be considered in SN positive patients, especially in younger HER2+ MIBC patients.

Original languageEnglish
JournalBreast Cancer Research and Treatment
Volume175
Issue number3
Pages (from-to)713-719
ISSN0167-6806
DOIs
Publication statusPublished - Jun 2019

    Research areas

  • Axillary lymphnode metastases, Axillary management, Axillary surgery, Early-stage breast cancer, Microinvasive breast cancer, Sentinel lymph node, Sentinel lymph node biopsy, Sentinel lymph node metastases, Age Factors, Sentinel Lymph Node Biopsy/methods, Humans, Middle Aged, Neoplasm Micrometastasis/pathology, Lymphatic Metastasis/pathology, Age of Onset, Denmark, Female, Registries, Aged, Retrospective Studies, Breast Neoplasms/metabolism, Receptor, ErbB-2/metabolism

ID: 57210533